Incidence of perforation and other mechanical complications during dual active fixation.
The intraoperative and early postoperative mechanical complications of a procedure combining an atrial screw-in lead and a ventricular screw-in lead insertion were prospectively evaluated. The procedure was performed in 119 consecutive patients (mean age 69 +/- 8 years), at first implant in 100 patients and at reoperation in 19. Nine patients had previously undergone cardiac surgery and three underwent transvenous ventricular defibrillator implantation. The double sets of leads were introduced through 2 separate veins in 5 cases, through a single venous route in 114 cases, using a percutaneous approach in 75 cases and a venous cutdown in 49, and a guidewire procedure following the venotomy in 19. The screw was mannitol coated in 102 cases, exposed in 111, and extendable/retractable in 25. The fixation of the ventricular lead was performed at the apex in 108 cases, at the outflow tract in 11, and was followed by the fixation of the atrial lead at the appendage in 112 cases and at the lateral wall in 7 cases. The lead positioning and fixation were successful at first attempt in 103 cases and after repeated lead manipulation in 19 cases. The rotational torque could be transferred to the helix in all cases except in one patient who required a second vein puncture. Unintentional fixation in the ventricular chamber with subsequent failure to remove the lead occurred in one patient. Reoperation for lead dislodgment was required in two patients. In one patient, symptomatic pericarditis with pericardial effusion was observed 1 day after the procedure and resolved spontaneously. Dual active fixation is feasible with a low incidence of mechanical complications.
Trigano
A J
AJ
Department of Cardiology, Centre Hospitalier Universitaire Nord, University of Marseille, School of Medicine, France.
Taramasco
V
V
Paganelli
F
F
Gerard
R
R
Lévy
S
S
D000368:Aged; D016275:Atrial Function; D006348:Cardiac Surgical Procedures; D002406:Catheterization, Peripheral; D017147:Defibrillators, Implantable; D004234:Diuretics, Osmotic / Q000737:chemistry; D004567:Electrodes, Implanted / Q000009:adverse effects*; D004867:Equipment Design; D005069:Evaluation Studies as Topic; D005240:Feasibility Studies; D005260:Female; D006325:Heart Atria; D006352:Heart Ventricles; D006801:Humans; D015994:Incidence; D007431:Intraoperative Complications; D008297:Male; D008353:Mannitol / Q000737:chemistry; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D010490:Pericardial Effusion / Q000209:etiology; D010493:Pericarditis / Q000209:etiology; D011183:Postoperative Complications; D011446:Prospective Studies; D012086:Reoperation; D013499:Surface Properties; D019415:Torque; D016748:Venous Cutdown; D016276:Ventricular Function
D004234:Diuretics, Osmotic; D008353:Mannitol